Clinical Trials · NCT02311608
Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 1,320
- Start date
- Feb 2014
- Locations
- 1 site, China
- Primary endpoint
- The Change of Rebleeding Rate